Eli Lilly shares tumble as company’s weight-loss drug misses Wall Street sales expectations
Open this photo in gallery:The Eli Lilly & Co. corporate headquarters, in Indianapolis, on April 26, 2017.Darron Cummings/The Associated PressEli...
Eli
Eli Lilly considers testing weight-loss drugs on people who are not overweight
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.Eli Lilly...
Eli Lilly, Novo Nordisk get growth stock status on weight-loss drug boost
(Repeats Feb 16 story with no changes to text)By Medha Singh and Manas Mishra(Reuters) - U.S.-based Eli Lilly and Denmark's...
